Anebulo Pharmaceuticals Inc. (NASDAQ: ANEB) Stock Information | RedChip

Anebulo Pharmaceuticals Inc. (NASDAQ: ANEB) Listen to this Section


$1.99
+0.0650 ( +3.38% ) 0.4K

Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company. It is developing novel solutions for people suffering from cannabinoid overdose and substance addiction. The product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within 1 hour of administration. The signs and symptoms of cannabinoid overdose range from profound sedation to anxiety and panic to psychosis with hallucinations.

Market Data


Open


$1.99

Previous close


$1.93

Volume


0.4K

Market cap


$50.31M

Day range


$1.91 - $2.01

52 week range


$1.62 - $4.05

Insider Ownership Transactions

Total Amount Purchased: -1,264,282.00 | $ -2,515,921.18

Date Type Amount Purchased Purchaser
2024-06-17 Sale -41667.00 Calloway Nathaniel
2024-06-17 Sale -41667.00 Lin Kenneth
2024-06-17 Sale -41667.00 Lawler Joseph F.
2024-06-17 Sale -41667.00 Aryeh Jason
2024-06-17 Sale -41667.00 SHAH BIMAL R.
2024-06-17 Sale -41667.00 English Aron R.
2024-06-17 Sale -41667.00 Kupchyk Areta
2024-03-01 Sale -72613.00 Cundy Kenneth C
2023-12-20 Sale -300000.00 English Aron R.
2023-10-11 Sale -600000.00 Cunningham, Richard Anthony

SEC Fillings


Form Type Description Pages Date
8-k 8K-related 15 Jul 22, 2024
4 Insider transactions 2 Jun 17, 2024
4 Insider transactions 2 Jun 17, 2024
8-k 8K-related 13 Jun 17, 2024
4 Insider transactions 2 Jun 17, 2024
4 Insider transactions 2 Jun 17, 2024
4 Insider transactions 2 Jun 17, 2024
4 Insider transactions 2 Jun 17, 2024
4 Insider transactions 1 Jun 17, 2024
8-k 8K-related 15 May 15, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.